WallStreetZenWallStreetZen

NASDAQ: ALIM
Alimera Sciences Inc Stock Forecast, Predictions & Price Target

Open Broker Account

Analyst price target for ALIM

Based on 1 analyst offering 12 month price targets for Alimera Sciences Inc.
Min Forecast
$9.00+57.07%
Avg Forecast
$9.00+57.07%
Max Forecast
$9.00+57.07%

Should I buy or sell ALIM stock?

Based on 1 analyst offering ratings for Alimera Sciences Inc.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their ALIM stock forecasts and price targets.

ALIM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
HC Wainwright & Co.
Top 5%
96
BuyMaintains$9.00+57.07%2022-07-28

1 of 1

Forecast return on equity

Is ALIM forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is ALIM forecast to generate an efficient return on assets?
Company
-8.38%
Industry
9.28%
ALIM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

ALIM earnings per share forecast

What is ALIM's earnings per share in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
-$1.85
Avg 2 year Forecast
-$0.57

ALIM revenue forecast

What is ALIM's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$59.2M+12.42%
Avg 2 year Forecast
$68.8M+30.76%
ALIM's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ALIM revenue growth forecast

How is ALIM forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
12.42%
Industry
4.24%
Market
15.15%
ALIM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ALIM's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ALIM vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
ALIM$5.73$9.00+57.07%Buy
QLI$1.12N/AN/A
DERM$2.39$12.67+430.00%Strong Buy
CPIX$2.47$8.50+244.13%Strong Buy
RDHL$0.63$15.70+2,412.00%Strong Buy

Alimera Sciences Stock Forecast FAQ

Is Alimera Sciences Stock a good buy in 2022, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: ALIM) stock is to Buy ALIM stock.

Out of 1 analyst, 0 (0%) are recommending ALIM as a Strong Buy, 1 (100%) are recommending ALIM as a Buy, 0 (0%) are recommending ALIM as a Hold, 0 (0%) are recommending ALIM as a Sell, and 0 (0%) are recommending ALIM as a Strong Sell.

If you're new to stock investing, here's how to buy Alimera Sciences stock.

What is ALIM's earnings growth forecast for 2022-2023?

(NASDAQ: ALIM) Alimera Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 151.75%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 52.44%.

Alimera Sciences's earnings in 2022 is -$17,359,000.On average, 1 Wall Street analyst forecast ALIM's earnings for 2022 to be -$12,941,603, with the lowest ALIM earnings forecast at -$12,941,603, and the highest ALIM earnings forecast at -$12,941,603.

In 2023, ALIM is forecast to generate -$3,987,413 in earnings, with the lowest earnings forecast at -$3,987,413 and the highest earnings forecast at -$3,987,413.

What is ALIM's revenue growth forecast for 2022-2023?

(NASDAQ: ALIM) Alimera Sciences's forecast annual revenue growth rate of 12.42% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 4.24%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 15.15%.

Alimera Sciences's revenue in 2022 is $52,614,000.On average, 1 Wall Street analysts forecast ALIM's revenue for 2022 to be $413,781,518, with the lowest ALIM revenue forecast at $413,781,518, and the highest ALIM revenue forecast at $413,781,518.

In 2023, ALIM is forecast to generate $481,287,717 in revenue, with the lowest revenue forecast at $481,287,717 and the highest revenue forecast at $481,287,717.

What is ALIM's forecast return on assets (ROA) for 2022-2023?

(NASDAQ: ALIM) forecast ROA is -8.38%, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 9.28%.

What is ALIM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year ALIM price target, the average ALIM price target is $9.00, with the highest ALIM stock price forecast at $9.00 and the lowest ALIM stock price forecast at $9.00.

The Wall Street analyst predicted that Alimera Sciences's share price could reach $9.00 by Jul 28, 2023. The average Alimera Sciences stock price prediction forecasts a potential upside of 57.07% from the current ALIM share price of $5.73.

What is ALIM's Earnings Per Share (EPS) forecast for 2022-2023?

(NASDAQ: ALIM) Alimera Sciences's current Earnings Per Share (EPS) is -$2.52. On average, analysts forecast that ALIM's EPS will be -$1.85 for 2022, with the lowest EPS forecast at -$1.85, and the highest EPS forecast at -$1.85. In 2023, ALIM's EPS is forecast to hit -$0.57 (min: -$0.57, max: -$0.57).

What is ALIM's forecast return on equity (ROE) for 2022-2023?

(NASDAQ: ALIM) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.